comparemela.com

Latest Breaking News On - Cancer therapy advisor - Page 10 : comparemela.com

First-Line Niraparib Maintenance Improves PFS in Advanced Ovarian Cancer

First-line maintenance with niraparib at an individualized starting dose improved progression-free survival in advanced ovarian cancer.

National cancer centerZai labCancer therapy advisor

Is First-Line Maintenance Underused in Advanced Ovarian Cancer?

A real-world study suggests that many patients with advanced ovarian cancer do not receive first-line maintenance therapy.

United statesUnited kingdomGenentech rocheKathleen mooreUniversity of oklahomaCancer therapy advisor

MAPK Mutations Linked to Better PFS, OS in Low-Grade Serous Ovarian Carcinoma

Patients with low-grade serous ovarian/peritoneal carcinoma have better outcomes if they have MAPK-mutated tumors, a study suggests.

United statesDavidm gershensonWolters kluwer healthUniversity of texas md anderson cancer centerBristol myers squibbCancer therapy advisorCancer center

Mirvetuximab Soravtansine: A New Standard of Care in Ovarian Cancer?

Mirvetuximab soravtansine produced responses in platinum-resistant, high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancers with high FRα expression.

United statesDana farber cancer instituteUrsulaa matulonisOvarian cancer research allianceRivkin foundationImmunogen incCancer therapy advisorBlueprint medicines

Risk of Cervical Cancer Recurrence Still 4 Times Higher With Minimally Invasive Surgery

Open radical hysterectomy provides better long-term outcomes than minimally invasive surgery in patients with early-stage cervical cancer.

United statesPedro ramirezUniversity of texas md anderson cancer centerCancer therapy advisorCancer center

vimarsana © 2020. All Rights Reserved.